Carpenter Declares Quarterly Cash Dividend
Apr 20, 2017 12:15 pm UTC| Business
PHILADELPHIA, April 20, 2017 -- Carpenter Technology Corporation (NYSE:CRS) announced that its Board of Directors has declared a quarterly cash dividend of $0.18 per share of common stock, payable June 1, 2017, to...
EHNAC Executive Director to Join Healthcare Industry Leaders at WEDI 2017
Apr 20, 2017 12:10 pm UTC| Business
FARMINGTON, Conn., April 20, 2017 -- The Electronic Healthcare Network Accreditation Commission (EHNAC) announced today that Executive Director Lee Barrett will join some of the biggest names in healthcare information...
Abeona to Present At Multiple Upcoming Conferences
Apr 20, 2017 12:05 pm UTC| Business
NEW YORK and CLEVELAND, April 20, 2017 -- Abeona Therapeutics Inc. (NASDAQ:ABEO), a leading clinical-stage biopharmaceutical company focused on developing novel gene therapies for life-threatening rare genetic diseases,...
Apr 20, 2017 12:05 pm UTC| Business
SOUTH SAN FRANCISCO, Calif., April 20, 2017 -- Mateon Therapeutics, Inc. (OTCQX:MATN), a biopharmaceutical company developing vascular disrupting agents (VDAs) for the treatment of orphan oncology indications, today...
Sprout Tiny Homes Corporate Update
Apr 20, 2017 12:04 pm UTC| Business
LA JUNTA, Colo., April 20, 2017 -- Sprout Tiny Homes (OTC PK:STHI) is pleased to announce collaboration and a partnership with WeeCasa (http://weecasa.com), known as the world’s largest tiny home hotel and resort,...
Wolters Kluwer Shareholders Adopt All Resolutions
Apr 20, 2017 12:02 pm UTC| Business
Wolters Kluwer Shareholders Adopt All Resolutions April 20, 2017 - Shareholders of Wolters Kluwer approved all resolutions at today's Annual General Meeting (AGM). In addition to adopting the financial statements for...
GRAIL Initiates the STRIVE Study to Advance Development of Blood Tests to Detect Cancer Early
Apr 20, 2017 12:02 pm UTC| Business
MENLO PARK, Calif., April 20, 2017 -- GRAIL, Inc., a life sciences company whose mission is to detect cancer early when it can be cured, today announced that it has commenced its second multi-center clinical study, the...